| scholarly article | Q13442814 |
| P2093 | author name string | Dana E Selley | |
| Allyn C Howlett | |||
| David C S Roberts | |||
| Steven R Childers | |||
| Caroline E Bass | |||
| Lawrence C Blume | |||
| Ruoyu Xiao | |||
| George D Dalton | |||
| Jasmine M Richardson | |||
| P2860 | cites work | Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus | Q24523073 |
| Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy | Q24535690 | ||
| Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats | Q44589971 | ||
| D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor | Q44666474 | ||
| A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission | Q44853701 | ||
| CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors. | Q45071453 | ||
| Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes | Q45076771 | ||
| The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease | Q45300428 | ||
| High levels of persistent expression of alpha1-antitrypsin mediated by the nonhuman primate serotype rh.10 adeno-associated virus despite preexisting immunity to common human adeno-associated viruses | Q45422901 | ||
| Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. | Q46691853 | ||
| Extracellular signal-regulated mitogen-activated protein kinase inhibitors decrease amphetamine-induced behavior and neuropeptide gene expression in the striatum | Q46928532 | ||
| Pretreatment with subeffective doses of Rimonabant attenuates orexigenic actions of orexin A-hypocretin 1. | Q46986060 | ||
| The lack of CB1 receptors prevents neuroadapatations of both NMDA and GABA(A) receptors after chronic ethanol exposure. | Q48198712 | ||
| Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. | Q48452719 | ||
| Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. | Q48658239 | ||
| Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain | Q73843429 | ||
| CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a | Q28250631 | ||
| Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis | Q28268078 | ||
| D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons | Q29615480 | ||
| Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens | Q30499463 | ||
| Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? | Q33211909 | ||
| Ligand-induced regulation and localization of cannabinoid CB1 and dopamine D2L receptor heterodimers | Q33714838 | ||
| Motor actions of cannabinoids in the basal ganglia output nuclei | Q33720160 | ||
| In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding | Q34039683 | ||
| Cocaine-induced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine | Q34145195 | ||
| Glial fibrillary acidic protein in chronic relapsing experimental allergic encephalomyelitis in SJL/J mice | Q34187443 | ||
| Architecture of cannabinoid signaling in mouse retina | Q34313968 | ||
| Upregulation of cannabinoid type 1 receptors in dopamine D2 receptor knockout mice is reversed by chronic forced ethanol consumption. | Q34419703 | ||
| Cannabinoid receptors in microglia of the central nervous system: immune functional relevance | Q34561539 | ||
| Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research | Q34595415 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi | Q34768688 | ||
| The cannabinoid system and immune modulation | Q35213813 | ||
| The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders | Q35586641 | ||
| Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability. | Q35655886 | ||
| CB1 Cannabinoid Receptor Expression in the Striatum: Association with Corticostriatal Circuits and Developmental Regulation | Q35820005 | ||
| Distribution of cannabinoid receptors in the central and peripheral nervous system. | Q36441196 | ||
| Basal ganglia macrocircuits | Q36820559 | ||
| Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains | Q37264478 | ||
| The endocannabinoid system as a target for the treatment of motor dysfunction | Q37394164 | ||
| Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum | Q37680104 | ||
| Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders. | Q37734568 | ||
| Activation of the rat dopamine D2 receptor promoter by mitogen-activated protein kinase and Ca2+/calmodulin-dependent protein kinase II pathways | Q40691654 | ||
| Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons | Q42450378 | ||
| Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease. | Q42478056 | ||
| Subchronic haloperidol increases CB(1) receptor binding and G protein coupling in discrete regions of the basal ganglia | Q42484267 | ||
| Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia | Q42486484 | ||
| Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. | Q42520647 | ||
| Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum. | Q43621342 | ||
| Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. | Q43873792 | ||
| Postsynaptic endocannabinoid release is critical to long-term depression in the striatum | Q43971441 | ||
| CB1 knockout mice display significant changes in striatal opioid peptide and D4 dopamine receptor gene expression. | Q44330387 | ||
| Region-specific up-regulation of opioid receptor binding in enkephalin knockout mice. | Q44352009 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | striatum | Q1319792 |
| P304 | page(s) | 808-820 | |
| P577 | publication date | 2013-01-31 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and δ opioid systems | |
| P478 | volume | 124 |
| Q37592641 | Acute Depletion of D2 Receptors from the Rat Substantia Nigra Alters Dopamine Kinetics in the Dorsal Striatum and Drug Responsivity |
| Q35582616 | Alterations in the Medullary Endocannabinoid System Contribute to Age-related Impairment of Baroreflex Sensitivity |
| Q51539430 | An Information Theoretical Study of the Epistasis Between the CNR1 1359 G/A Polymorphism and the Taq1A and Taq1B DRD2 Polymorphisms: Assessing the Susceptibility to Cannabis Addiction in a Turkish Population. |
| Q59127752 | Blockade of Rostral Ventrolateral Medulla Apelin Receptors Does Not Attenuate Arterial Pressure in SHR and -NAME-Induced Hypertensive Rats |
| Q90722427 | Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure |
| Q38728533 | Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites |
| Q38935678 | Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells |
| Q38738659 | Cannabinoid receptor interacting protein suppresses agonist-driven CB1 receptor internalization and regulates receptor replenishment in an agonist-biased manner |
| Q35198030 | Cannabinoid receptor-interacting protein 1a modulates CB1 receptor signaling and regulation |
| Q41220110 | Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus |
| Q37617401 | Chronic alcohol disrupts dopamine receptor activity and the cognitive function of the medial prefrontal cortex |
| Q35956109 | Chronic baclofen desensitizes GABA(B)-mediated G-protein activation and stimulates phosphorylation of kinases in mesocorticolimbic rat brain. |
| Q39109270 | Crosstalk between dopamine D₂ receptors and cannabinoid CB₁ receptors regulates CNR1 promoter activity via ERK1/2 signaling. |
| Q47562104 | Different effects of chronic THC on the neuroadaptive response of dopamine D2/3 receptor-mediated signaling in roman high- and roman low-avoidance rats. |
| Q36019618 | Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder. |
| Q47790895 | In silico interaction analysis of cannabinoid receptor interacting protein 1b (CRIP1b) - CB1 cannabinoid receptor |
| Q48386775 | Low-frequency stimulation evokes serotonin release in the nucleus accumbens and induces long-term depression via production of endocannabinoid |
| Q30842363 | Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe |
| Q36821806 | Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior |
| Q28276192 | Sulfation of the FLAG epitope is affected by co-expression of G protein-coupled receptors in a mammalian cell model |
| Q40961560 | The Cannabinoid Receptor Interacting Proteins 1 of zebrafish are not required for morphological development, viability or fertility. |
| Q50422457 | The cannabinoid-1 receptor is abundantly expressed in striatal striosomes and striosome-dendron bouquets of the substantia nigra |
| Q37381132 | Trajectory of adolescent cannabis use on addiction vulnerability |
| Q90314548 | Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat |
| Q47559633 | Ventral tegmental area D2 receptor knockdown enhances choice impulsivity in a delay-discounting task in rats |
| Q50602816 | cnrip1 is a regulator of eye and neural development in Xenopus laevis. |
| Q30564022 | ΔFosB induction correlates inversely with CB₁ receptor desensitization in a brain region-dependent manner following repeated Δ⁹-THC administration |
Search more.